Atopic Dermatitis Study (48 Weeks)

For condition: Atopic Dermatitis
For condition: Eczema – Atopic Dermatitis

Atopic Dermatitis Study (48 Weeks)

Study Summary

Who Can Participate?

Adults aged ≥ 18 years with moderate to severe AD may participate.

 

Inclusion Criteria

      • have AD involvement of ≥ 10% body surface area (BSA)*
      • AD diagnosis confirmed by a dermatologist according to the Hanifin/Rajka criteria >=1year prior to SCN
      • documented history (<=12mo of SCN) of inadequate response to topical corticosteroids (TCS) or topical calcineurin inhibitors (TCI)
      • no past or current use of dupilumab or any systemic or topical JAK inhibitors

* 1% of your body surface area is roughly equal to the palm of your hand (no wrists or fingers).

 

Participant Information

      • Participate and receive study treatment at no cost
      • Regular visits with study doctors who specialise in treating atopic dermatitis (up to 16 visits)
      • Will receive an investigative subcutaneous treatment (study drug) or a placebo
      • Reimbursement for study-related expenses may be provided

 

How Long Will the Study Last?

48 weeks

Click here to Register

For more information about this trial, please visit ClinicalTrials.gov

Ready to Find a Trial?

Start your journey here.
Find a Trial

Can’t Find a Trial Near You?

Complete a general registration to let us know who you are and what you’re interested in. We can keep your information on file and contact you when there is a trial that may be suitable for you.
General Registration

Privacy Policy

Last Revised: July 2024

I agree to the Privacy PolicyI do not agree

Registration

Enrolling:

Clinic:

Doctor:

Please fill in your contact details:

Find a Trial